Evidence map›Paper›PMID 40142147›Full record

ArticleMolecules (Basel, Switzerland)2025

Cross-Analytical Strategies to Tackle "Medicines in Disguise" Presented as Food Supplements, a New Threat for Human Health.

Judith Nzoughet Kouassi, Chouaha Bouzidi, Béatrice Nicolai, Farah Ben Jamaa, Annabelle Dugay, Jérôme Langrand, Dominique Vodovar, Pascal Houzé, Laurence Labat, Bruno Mégarbane and 5 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Judith Nzoughet KouassiUFR de Pharmacie, Faculté de Santé, Université Paris Cité, CNRS, Cibles Thérapeutiques et Conception de Medicaments, UMR 8038, F-75006 Paris, France.ORCID 0000-0003-4987-1889
Chouaha BouzidiUFR de Pharmacie, Faculté de Santé, Université Paris Cité, CNRS, Cibles Thérapeutiques et Conception de Medicaments, UMR 8038, F-75006 Paris, France.
Béatrice NicolaiUFR de Pharmacie, Faculté de Santé, Université Paris Cité, CNRS, Cibles Thérapeutiques et Conception de Medicaments, UMR 8038, F-75006 Paris, France.
Farah Ben JamaaUFR de Pharmacie, Faculté de Santé, Université Paris Cité, CNRS, Cibles Thérapeutiques et Conception de Medicaments, UMR 8038, F-75006 Paris, France.
Annabelle DugayUFR de Pharmacie, Faculté de Santé, Université Paris Cité, CNRS, Cibles Thérapeutiques et Conception de Medicaments, UMR 8038, F-75006 Paris, France.
Jérôme LangrandCentre Antipoison et de Toxicovigilance de Paris, Hôpital Fernand-Widal APHP, Inserm UMR-S 1144, F-75010 Paris, France.
Dominique VodovarCentre Antipoison et de Toxicovigilance de Paris, Hôpital Fernand-Widal APHP, Inserm UMR-S 1144, F-75010 Paris, France.
Pascal HouzéLaboratoire de Toxicologie, Hôpital Lariboisière APHP, Inserm UMR-S 1144, F-75010 Paris, France.
Laurence LabatLaboratoire de Toxicologie, Hôpital Lariboisière APHP, Inserm UMR-S 1144, F-75010 Paris, France.ORCID 0000-0001-8291-3054
Bruno MégarbaneRéanimation Médicale et Toxicologique, Hôpital Lariboisière APHP, Inserm UMR-S 1144, F-75010 Paris, France.ORCID 0000-0002-2522-2764
Cinzia BoccaFaculté de Santé, Institut MITOVASC, Université d'Angers, UMR CNRS 6015, INSERM U1083, F-49000 Angers, France.ORCID 0000-0002-8822-9832
Pascal ReynierFaculté de Santé, Institut MITOVASC, Université d'Angers, UMR CNRS 6015, INSERM U1083, F-49000 Angers, France.ORCID 0000-0003-0802-4608
Nicolas GuiblinLaboratoire SPMS, Centrale Supelec, Université Paris Saclay, Plateau de Moulon 3 rue Joliot-Curie, F-91192 Gif-sur-Yvette, France.ORCID 0000-0002-4418-0547
Sylvie MichelUFR de Pharmacie, Faculté de Santé, Université Paris Cité, CNRS, Cibles Thérapeutiques et Conception de Medicaments, UMR 8038, F-75006 Paris, France.ORCID 0000-0002-3993-4041
Xavier CachetUFR de Pharmacie, Faculté de Santé, Université Paris Cité, CNRS, Cibles Thérapeutiques et Conception de Medicaments, UMR 8038, F-75006 Paris, France.

Funding

IdEx Université Paris Cité ANR-18-IDEX-0001
6 · The paper itself

Abstract

Plant-based food supplements (FS) of doubtful traceability have now emerged as a new threat to human health. Food supplements adulterated with pharmaceutical ingredients are considered "medicines in disguise" by regulatory authorities, which is a sub-category of falsified medicines. In the context of illegal manufacture and trade, as well as in the absence of an official phyto- and/or pharmacovigilance system, emergency departments and poison control centers constitute a early warning system for detecting ingested suspect FS. In the present investigation, we set up efficient workflows for the systematic characterization of adulterated plant-based FS in the context of an original local early warning alert system (i.e., FalsiMedTrack) involving an emergency department, a poison center, and academic analytical chemistry laboratories. Fit-for-purpose cross-analytical methods were employed, including sophisticated methods such as liquid chromatography coupled to high-resolution mass spectrometry, nuclear magnetic resonance, X-ray powder diffraction, as well as the most accessible and affordable HPLC method with UV/DAD detection. The strategy was applied successfully to typical cases of suspect plant-based health products, i.e., sample incriminated in patients experiencing side effects and herbal products currently commercialized for their "amazing health benefits". The samples contained active pharmaceutical ingredients, including diclofenac, piroxicam, dexamethasone 21-acetate, and sibutramine. We provided evidence of "medicines in disguise" presented as food supplements, which raises concerns about their quality and safety.

Indexed as

Counterfeit DrugsDietary SupplementsChromatography, High Pressure LiquidHumansMagnetic Resonance SpectroscopyMass SpectrometryCounterfeit Drugsadulterationhigh-resolution mass spectrometry (HRMS)liquid chromatography (LC)medicine in disguisenuclear magnetic resonance (NMR)plant-based food supplementX-ray powder diffraction (XRPD)

Identifiers

PMID40142147
PMCPMC11944288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.